Correlation Between Phathom Pharmaceuticals and Clearpoint Neuro

Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and Clearpoint Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and Clearpoint Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phathom Pharmaceuticals and Clearpoint Neuro, you can compare the effects of market volatilities on Phathom Pharmaceuticals and Clearpoint Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of Clearpoint Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and Clearpoint Neuro.

Diversification Opportunities for Phathom Pharmaceuticals and Clearpoint Neuro

-0.49

Correlation Coefficient

Phathom Pharmaceuticals  Clearpoint Neuro

Very good diversification

The 3 months correlation between Phathom and Clearpoint is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and Clearpoint Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearpoint Neuro and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with Clearpoint Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearpoint Neuro has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and Clearpoint Neuro go up and down completely randomly.

Pair Corralation between Phathom Pharmaceuticals and Clearpoint Neuro

Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to generate 3.63 times more return on investment than Clearpoint Neuro. However, Phathom Pharmaceuticals is 3.63 times more volatile than Clearpoint Neuro. It trades about 0.19 of its potential returns per unit of risk. Clearpoint Neuro is currently generating about -0.12 per unit of risk. If you would invest  258.00  in Phathom Pharmaceuticals on May 3, 2025 and sell it today you would earn a total of  576.00  from holding Phathom Pharmaceuticals or generate 223.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Phathom Pharmaceuticals  vs.  Clearpoint Neuro

Phathom Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Phathom Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Phathom Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Clearpoint Neuro

Risk-Adjusted Performance

Very Weak

Over the last 90 days Clearpoint Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Phathom Pharmaceuticals and Clearpoint Neuro

The main advantage of trading using opposite Phathom Pharmaceuticals and Clearpoint Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, Clearpoint Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will offset losses from the drop in Clearpoint Neuro's long position.

The idea behind Phathom Pharmaceuticals and Clearpoint Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.